Logo image of PHI

PLDT INC-SPON ADR (PHI) Stock Fundamental Analysis

NYSE:PHI - New York Stock Exchange, Inc. - US69344D4088 - ADR - Currency: USD

22.87  -0.17 (-0.74%)

After market: 22.87 0 (0%)

Fundamental Rating

4

Overall PHI gets a fundamental rating of 4 out of 10. We evaluated PHI against 21 industry peers in the Wireless Telecommunication Services industry. PHI has an excellent profitability rating, but there are concerns on its financial health. PHI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

PHI had positive earnings in the past year.
PHI had a positive operating cash flow in the past year.
Of the past 5 years PHI 4 years were profitable.
Of the past 5 years PHI 4 years had a positive operating cash flow.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20B -20B 40B 60B 80B

1.2 Ratios

With a decent Return On Assets value of 4.31%, PHI is doing good in the industry, outperforming 71.43% of the companies in the same industry.
PHI has a better Return On Equity (23.95%) than 95.24% of its industry peers.
The Return On Invested Capital of PHI (7.91%) is better than 71.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PHI is in line with the industry average of 6.12%.
The 3 year average ROIC (5.70%) for PHI is below the current ROIC(7.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.31%
ROE 23.95%
ROIC 7.91%
ROA(3y)3.41%
ROA(5y)3.74%
ROE(3y)18.73%
ROE(5y)19.45%
ROIC(3y)5.7%
ROIC(5y)7.07%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

PHI has a better Profit Margin (12.41%) than 90.48% of its industry peers.
PHI's Profit Margin has improved in the last couple of years.
PHI has a better Operating Margin (20.26%) than 71.43% of its industry peers.
PHI's Operating Margin has improved in the last couple of years.
The Gross Margin of PHI (87.28%) is better than 95.24% of its industry peers.
In the last couple of years the Gross Margin of PHI has remained more or less at the same level.
Industry RankSector Rank
OM 20.26%
PM (TTM) 12.41%
GM 87.28%
OM growth 3Y-3.65%
OM growth 5Y12.93%
PM growth 3Y-2.02%
PM growth 5Y1.92%
GM growth 3Y-1.34%
GM growth 5Y0.25%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

1

2. Health

2.1 Basic Checks

PHI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for PHI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200B 400B 600B

2.2 Solvency

PHI has an Altman-Z score of 0.73. This is a bad value and indicates that PHI is not financially healthy and even has some risk of bankruptcy.
PHI has a Altman-Z score of 0.73. This is in the lower half of the industry: PHI underperforms 66.67% of its industry peers.
The Debt to FCF ratio of PHI is 11.64, which is on the high side as it means it would take PHI, 11.64 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PHI (11.64) is worse than 61.90% of its industry peers.
PHI has a Debt/Equity ratio of 2.66. This is a high value indicating a heavy dependency on external financing.
PHI has a worse Debt to Equity ratio (2.66) than 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.66
Debt/FCF 11.64
Altman-Z 0.73
ROIC/WACC1.3
WACC6.08%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100B 200B

2.3 Liquidity

PHI has a Current Ratio of 0.34. This is a bad value and indicates that PHI is not financially healthy enough and could expect problems in meeting its short term obligations.
PHI's Current ratio of 0.34 is on the low side compared to the rest of the industry. PHI is outperformed by 95.24% of its industry peers.
PHI has a Quick Ratio of 0.34. This is a bad value and indicates that PHI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.32, PHI is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.32
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B 200B

2

3. Growth

3.1 Past

PHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.58%.
Measured over the past 5 years, PHI shows a small growth in Earnings Per Share. The EPS has been growing by 5.18% on average per year.
EPS 1Y (TTM)6.58%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%2.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.37%

3.2 Future

PHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.80% yearly.
PHI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.44% yearly.
EPS Next Y3.96%
EPS Next 2Y4.64%
EPS Next 3Y3.8%
EPS Next 5YN/A
Revenue Next Year4%
Revenue Next 2Y3.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

6

4. Valuation

4.1 Price/Earnings Ratio

PHI is valuated reasonably with a Price/Earnings ratio of 8.02.
Based on the Price/Earnings ratio, PHI is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.63, PHI is valued rather cheaply.
The Price/Forward Earnings ratio is 7.71, which indicates a rather cheap valuation of PHI.
Based on the Price/Forward Earnings ratio, PHI is valued cheaper than 90.48% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.85. PHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.02
Fwd PE 7.71
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as PHI.
PHI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 10.09
EV/EBITDA 5.69
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHI does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of PHI may justify a higher PE ratio.
PEG (NY)2.03
PEG (5Y)1.55
EPS Next 2Y4.64%
EPS Next 3Y3.8%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.54%, PHI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.53, PHI pays a better dividend. On top of this PHI pays more dividend than 85.71% of the companies listed in the same industry.
PHI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 7.54%

5.2 History

The dividend of PHI is nicely growing with an annual growth rate of 10.72%!
PHI has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)10.72%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

78.06% of the earnings are spent on dividend by PHI. This is not a sustainable payout ratio.
PHI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP78.06%
EPS Next 2Y4.64%
EPS Next 3Y3.8%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

PLDT INC-SPON ADR

NYSE:PHI (4/21/2025, 8:04:00 PM)

After market: 22.87 0 (0%)

22.87

-0.17 (-0.74%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-27 2025-02-27/dmh
Earnings (Next)05-01 2025-05-01
Inst Owners5.78%
Inst Owner Change0.5%
Ins Owners0.74%
Ins Owner ChangeN/A
Market Cap4.94B
Analysts82.5
Price Target30.61 (33.84%)
Short Float %0.16%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield 7.54%
Yearly Dividend1.92
Dividend Growth(5Y)10.72%
DP78.06%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-12 2025-03-12 (0.821086)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.62%
Min EPS beat(2)-4.35%
Max EPS beat(2)-0.89%
EPS beat(4)2
Avg EPS beat(4)5.04%
Min EPS beat(4)-4.35%
Max EPS beat(4)22.14%
EPS beat(8)6
Avg EPS beat(8)16.1%
EPS beat(12)10
Avg EPS beat(12)16.17%
EPS beat(16)14
Avg EPS beat(16)14.26%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.42%
PT rev (3m)-1.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)4.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.6%
Valuation
Industry RankSector Rank
PE 8.02
Fwd PE 7.71
P/S 1.3
P/FCF 10.09
P/OCF 3.18
P/B 2.51
P/tB 5.91
EV/EBITDA 5.69
EPS(TTM)2.85
EY12.46%
EPS(NY)2.97
Fwd EY12.98%
FCF(TTM)2.27
FCFY9.91%
OCF(TTM)7.19
OCFY31.44%
SpS17.6
BVpS9.12
TBVpS3.87
PEG (NY)2.03
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA 4.31%
ROE 23.95%
ROCE 10.24%
ROIC 7.91%
ROICexc 8.16%
ROICexgc 9.66%
OM 20.26%
PM (TTM) 12.41%
GM 87.28%
FCFM 12.88%
ROA(3y)3.41%
ROA(5y)3.74%
ROE(3y)18.73%
ROE(5y)19.45%
ROIC(3y)5.7%
ROIC(5y)7.07%
ROICexc(3y)6.3%
ROICexc(5y)7.93%
ROICexgc(3y)7.62%
ROICexgc(5y)9.93%
ROCE(3y)7.38%
ROCE(5y)9.15%
ROICexcg growth 3Y-7.9%
ROICexcg growth 5Y2.59%
ROICexc growth 3Y-6.16%
ROICexc growth 5Y6.33%
OM growth 3Y-3.65%
OM growth 5Y12.93%
PM growth 3Y-2.02%
PM growth 5Y1.92%
GM growth 3Y-1.34%
GM growth 5Y0.25%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 2.66
Debt/FCF 11.64
Debt/EBITDA 2.87
Cap/Depr 100.84%
Cap/Sales 27.97%
Interest Coverage 4.29
Cash Conversion 85.1%
Profit Quality 103.8%
Current Ratio 0.34
Quick Ratio 0.32
Altman-Z 0.73
F-Score5
WACC6.08%
ROIC/WACC1.3
Cap/Depr(3y)139.77%
Cap/Depr(5y)159.58%
Cap/Sales(3y)46.01%
Cap/Sales(5y)46.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.58%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%2.61%
EPS Next Y3.96%
EPS Next 2Y4.64%
EPS Next 3Y3.8%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.37%
Revenue Next Year4%
Revenue Next 2Y3.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.37%
EBIT growth 3Y1.39%
EBIT growth 5Y18.66%
EBIT Next Year113.71%
EBIT Next 3Y32.27%
EBIT Next 5Y24.54%
FCF growth 1Y218.69%
FCF growth 3Y1.66%
FCF growth 5Y-9.9%
OCF growth 1Y16.97%
OCF growth 3Y0.27%
OCF growth 5Y7.01%